Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in medical imaging and in therapy for many diseases (for example, brachytherapy). Many radiopharmaceuticals use technetium-99m (Tc-99m) which has many useful properties as a gamma-emitting tracer nuclide.
In the last several years, global market of Radiopharmaceuticals developed year by year, with an average growth rate of 8.02% for the sales. In 2016, global revenue of Radiopharmaceuticals is nearly 4546 M USD; the sale is about 130 M Dose.
The classification of Radiopharmaceuticals includes Diagnostic Radioisotopes, Therapeutic Radioisotopes. The proportion of Diagnostic Radioisotopes in 2016 is about 89.22%, and the proportion is in decreasing trend from 2012 to 2017. The Therapeutic Radioisotopes is enjoying more and more market share.
Radiopharmaceuticals are widely used in Oncology, Cardiology and Other disease diagnosis and treatment. The most of radiopharmaceuticals is used in Oncology, and the sales proportion in 2016 is about 62.63%.
According to this study, over the next five years the Radiopharmaceuticals market will register a 7.8% CAGR in terms of revenue, the global market size will reach US$ 7130 million by 2024, from US$ 4900 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Radiopharmaceuticals business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Radiopharmaceuticals market by product type, application, key manufacturers and key regions and countries.
This study considers the Radiopharmaceuticals value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Diagnostic Radioisotopes
Therapeutic Radioisotopes
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Oncology
Cardiology
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Bracco Imaging
Bayer
Mallinckrodt
Nordion
Triad Isotopes
Lantheus
IBA Group
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Advanced Accelerator Applications
SIEMENS
Dongcheng
Navidea
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Radiopharmaceuticals consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Radiopharmaceuticals market by identifying its various subsegments.
Focuses on the key global Radiopharmaceuticals manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Radiopharmaceuticals with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Radiopharmaceuticals submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Radiopharmaceuticals Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Radiopharmaceuticals Consumption 2014-2024
2.1.2 Radiopharmaceuticals Consumption CAGR by Region
2.2 Radiopharmaceuticals Segment by Type
2.2.1 Diagnostic Radioisotopes
2.2.2 Therapeutic Radioisotopes
2.3 Radiopharmaceuticals Consumption by Type
2.3.1 Global Radiopharmaceuticals Consumption Market Share by Type (2014-2019)
2.3.2 Global Radiopharmaceuticals Revenue and Market Share by Type (2014-2019)
2.3.3 Global Radiopharmaceuticals Sale Price by Type (2014-2019)
2.4 Radiopharmaceuticals Segment by Application
2.4.1 Oncology
2.4.2 Cardiology
2.4.3 Other
2.5 Radiopharmaceuticals Consumption by Application
2.5.1 Global Radiopharmaceuticals Consumption Market Share by Application (2014-2019)
2.5.2 Global Radiopharmaceuticals Value and Market Share by Application (2014-2019)
2.5.3 Global Radiopharmaceuticals Sale Price by Application (2014-2019)
3 Global Radiopharmaceuticals by Players
3.1 Global Radiopharmaceuticals Sales Market Share by Players
3.1.1 Global Radiopharmaceuticals Sales by Players (2017-2019)
3.1.2 Global Radiopharmaceuticals Sales Market Share by Players (2017-2019)
3.2 Global Radiopharmaceuticals Revenue Market Share by Players
3.2.1 Global Radiopharmaceuticals Revenue by Players (2017-2019)
3.2.2 Global Radiopharmaceuticals Revenue Market Share by Players (2017-2019)
3.3 Global Radiopharmaceuticals Sale Price by Players
3.4 Global Radiopharmaceuticals Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Radiopharmaceuticals Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Radiopharmaceuticals Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Radiopharmaceuticals by Regions
4.1 Radiopharmaceuticals by Regions
4.1.1 Global Radiopharmaceuticals Consumption by Regions
4.1.2 Global Radiopharmaceuticals Value by Regions
4.2 Americas Radiopharmaceuticals Consumption Growth
4.3 APAC Radiopharmaceuticals Consumption Growth
4.4 Europe Radiopharmaceuticals Consumption Growth
4.5 Middle East & Africa Radiopharmaceuticals Consumption Growth
5 Americas
5.1 Americas Radiopharmaceuticals Consumption by Countries
5.1.1 Americas Radiopharmaceuticals Consumption by Countries (2014-2019)
5.1.2 Americas Radiopharmaceuticals Value by Countries (2014-2019)
5.2 Americas Radiopharmaceuticals Consumption by Type
5.3 Americas Radiopharmaceuticals Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Radiopharmaceuticals Consumption by Countries
6.1.1 APAC Radiopharmaceuticals Consumption by Countries (2014-2019)
6.1.2 APAC Radiopharmaceuticals Value by Countries (2014-2019)
6.2 APAC Radiopharmaceuticals Consumption by Type
6.3 APAC Radiopharmaceuticals Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Radiopharmaceuticals by Countries
7.1.1 Europe Radiopharmaceuticals Consumption by Countries (2014-2019)
7.1.2 Europe Radiopharmaceuticals Value by Countries (2014-2019)
7.2 Europe Radiopharmaceuticals Consumption by Type
7.3 Europe Radiopharmaceuticals Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Radiopharmaceuticals by Countries
8.1.1 Middle East & Africa Radiopharmaceuticals Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Radiopharmaceuticals Value by Countries (2014-2019)
8.2 Middle East & Africa Radiopharmaceuticals Consumption by Type
8.3 Middle East & Africa Radiopharmaceuticals Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Radiopharmaceuticals Distributors
10.3 Radiopharmaceuticals Customer
11 Global Radiopharmaceuticals Market Forecast
11.1 Global Radiopharmaceuticals Consumption Forecast (2019-2024)
11.2 Global Radiopharmaceuticals Forecast by Regions
11.2.1 Global Radiopharmaceuticals Forecast by Regions (2019-2024)
11.2.2 Global Radiopharmaceuticals Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Radiopharmaceuticals Forecast by Type
11.8 Global Radiopharmaceuticals Forecast by Application
12 Key Players Analysis
12.1 Bracco Imaging
12.1.1 Company Details
12.1.2 Radiopharmaceuticals Product Offered
12.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Bracco Imaging News
12.2 Bayer
12.2.1 Company Details
12.2.2 Radiopharmaceuticals Product Offered
12.2.3 Bayer Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Bayer News
12.3 Mallinckrodt
12.3.1 Company Details
12.3.2 Radiopharmaceuticals Product Offered
12.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 Mallinckrodt News
12.4 Nordion
12.4.1 Company Details
12.4.2 Radiopharmaceuticals Product Offered
12.4.3 Nordion Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Nordion News
12.5 Triad Isotopes
12.5.1 Company Details
12.5.2 Radiopharmaceuticals Product Offered
12.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Triad Isotopes News
12.6 Lantheus
12.6.1 Company Details
12.6.2 Radiopharmaceuticals Product Offered
12.6.3 Lantheus Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Lantheus News
12.7 IBA Group
12.7.1 Company Details
12.7.2 Radiopharmaceuticals Product Offered
12.7.3 IBA Group Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.7.4 Main Business Overview
12.7.5 IBA Group News
12.8 GE Healthcare
12.8.1 Company Details
12.8.2 Radiopharmaceuticals Product Offered
12.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.8.4 Main Business Overview
12.8.5 GE Healthcare News
12.9 China Isotope & Radiation
12.9.1 Company Details
12.9.2 Radiopharmaceuticals Product Offered
12.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.9.4 Main Business Overview
12.9.5 China Isotope & Radiation News
12.10 Jubilant Pharma
12.10.1 Company Details
12.10.2 Radiopharmaceuticals Product Offered
12.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue, Price and Gross Margin (2017-2019)
12.10.4 Main Business Overview
12.10.5 Jubilant Pharma News
12.11 Eli Lilly
12.12 Advanced Accelerator Applications
12.13 SIEMENS
12.14 Dongcheng
12.15 Navidea
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Radiopharmaceuticals
Table Product Specifications of Radiopharmaceuticals
Figure Radiopharmaceuticals Report Years Considered